FGP
SNDX icon

Freestone Grove Partners’s Syndax Pharmaceuticals SNDX Stock Holding History

Freestone Grove Partners’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$145K Sell
15,457
-1,507
-9% -$14.1K ﹤0.01% 642
2025
Q1 		$208K Buy
+16,964
New +$208K ﹤0.01% 535